Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000245

EVP Research sold 27,114 shares at an average $66.16 ($1,793,744)

  • EVP Research acquired 27,114 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Swayze Eric · EVP Research

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-01 Exercise or conversion : show line 1 in the form 10b5-1 +14,142 $53.77 $760,415 51,444 D
2025-10-01 Sale : show line 2 in the form 10b5-1 −14,142 $66.09 $934,662 37,302 D
2025-10-02 Exercise or conversion : show line 3 in the form 10b5-1 +12,972 $53.77 $697,504 50,274 D
2025-10-02 Sale : show line 4 in the form 10b5-1 −12,972 $66.23 $859,082 37,302 D
Open-market sales · 27,114 sh · avg $66.16 · $1,793,744

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-10-01 Exercise or conversion : show line 5 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −14,142 12,972 D
2025-10-02 Exercise or conversion : show line 6 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −12,972 0 D
Loading xslF345X05/edgardoc.xml…